FDA OKs Baxalta’s drug for von Willebrand bleeding disorderFDA OKs Baxalta’s drug for von Willebrand bleeding disorderAccording to the FDA, von Willebrand disease affects about 1 percent of the U.S. population, or more than 3 million Americans.Associated PressAssociated Press
